Mogrify

Pierre-Louis Joffrin

Corporate Development Executive

Darrin Disley

CEO

Darrin brings scientific and entrepreneurial experience, serving as Executive Chairman at Cardiogeni Plc and Managing Director at Roquefort Therapeutics Plc. He previously held leadership roles including CEO at Mogrify and principal at Carpe Diem Investment Fund.

Karin Schmitt

CBO

Karin brings operational and business leadership experience from roles including Chief Operating Officer at Mursla Bio and Chief Business Officer at Mogrify. Her background also includes research operations at PredictImmune and R&D direction at Horizon Discovery.

Jane Osbourn

Chair

Jane serves as chief executive of Alchemab Therapeutics and chairs Mogrify. Her career includes roles as chief scientific officer at Alchemab and chair of the BioIndustry Association.

Lorenz Mayr

Non-Executive Director

Lorenz brings governance and advisory experience across multiple life sciences and investment organisations, including roles as managing director at BioMedTech Consulting, board member at the Francis Crick Institute, and senior advisor at EQT Group. He holds non-executive and chair positions at Mogrify, FundaMental Pharma, and InCephalo.